Menu

Nature Debuts Peer-Review Option

Authors submitting to Nature journals can soon request double-blind reviews.

Feb 18, 2015
Tracy Vence

FLICKR, PETE O'SHEABeginning next month, authors submitting their work to Nature and its associated journals can request double-blind peer review, in which the authors’ names and affiliations will be withheld from reviewers (much like reviewers’ names and affiliations are currently withheld from the authors).

“Advocates of double-blind peer review suggest that it eliminates personal biases, such as those based on gender, seniority, reputation and affiliation,” Nature noted in its February 18 announcement.

In contrast, some researchers have advocated for open peer review, in which the authors and reviewers both are clearly identified, arguing that such increased transparency might further limit bias. But some open-peer-review advocates, such as PhD student Matthew Evans of the John Innes Centre in Norwich, U.K., suggest that, if reviews are to be blinded, double-blind is preferable to single-blind peer review.

“Good scientists will continue to publish good papers in good journals under a double-blind peer review system,” wrote Boyan Garvalov of Justus Liebig University Giessen, Germany, in a January Advances in Regenerative Biology article (hat tip: Alexis Verger). “But every now and again a lesser known research team could make it on the strength of their work against a more famous one, when they would have failed in the single-blind setting—and this would be reason enough for me to endorse the shift to double-blind review.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.